Partner with us
For ophthalmologists & optometrists

Bring OcuLenz to your low-vision patients.

OcuLenz is an AR/XR aid for advanced AMD and other low-vision conditions. Be the first in your area to offer it — with a demo unit, clinical support, and founding-partner standing in your territory.

A patient using OcuLenz at home
Regulatory status

Available now.

OcuLenz is a Class I medical device, exempt from 510(k) premarket notification. Ocutrx is FDA establishment registered and the device is listed with FDA. Available today, without a prescription, and no investigational device exemption is required for on-label use.

FDA device classification
Class I
Exempt from 510(k) premarket notification. Establishment registered; device listed with FDA.
For ophthalmologists & optometrists

Join the clinical partner program.

We're recruiting a small cohort of forward-looking ophthalmology and optometry practices as clinical partners. You get a demo unit, a direct line to our clinical team, and founding-partner standing in your territory — before we open broadly.

  • On-site demo unit & fitting protocol
  • Direct clinical support from our optometry lead
  • Early access to imaging, field, and outcomes data
  • Co-marketing in your region once live
~20M
US adults w/ vision loss
~1.8M
w/ advanced AMD
6 hrs
OcuLenz active battery
Class I
FDA device listing
Clinical partner — express interest
We'll reach out within 2 business days. No patient data requested or stored.

Looking for the patient experience, or want to see what your patients will see? Visit the OcuLenz patient page.

OcuLenz for patients
OcuLenz is a Class I medical device, exempt from 510(k) premarket notification. Ocutrx Technologies is FDA establishment registered and the device is listed with FDA. Intended for use by patients with low vision, including advanced age-related macular degeneration. OcuLenz is not a treatment or cure for any disease. Individual results vary.